Pinned Tweet
This was during fellowship more than a year ago #ASH2020. #LateTweet
Our love for Clonal 🍅poiesis keeps growing #FatherDaughter and #CH #HappyDaddy #HappyDaughter … Looking forward to many years of #TrackingClones
Abhay Singh retweeted
When GLP-1s Fall Short, What’s Next?
Not everyone can tolerate GLP-1s (#semaglutide #tirzepatide) or achieve enough weight loss.
A @ClevelandClinic study found that bariatric surgery can still deliver substantial weight loss in these patients.
What's next if GLP-1 medications don't work for you?
A new Cleveland Clinic study finds patients can still achieve substantial weight loss after bariatric surgery.
Read more: cle.clinic/4iw73h1
Abhay Singh retweeted
As awareness of CHIP 🧬 and its CV implications 📈, a key❓remains: When should hematologists refer pts for CV eval? In our @JACCJournals VP, we propose a practical framework we created @ClevelandClinic
Great working with @venumenon10 @CloneTracker, @CarrawayHetty
Linke below
Abhay Singh retweeted
In 48 hours, Nashville.
This photo is from our final planning meeting at @binaytara.
Starting Friday, the National Summit on Hematologic Cancers brings together the clinicians and researchers moving this field forward. Looking forward to the Impact Pitch, where finalists will compete for $200K @myelomaMD Shaji Kumar Hematology Research Award, to turn their ideas into real change for patients.
We can’t wait for you to see it. To everyone joining us, safe travels.
#Hematology #BloodCancer #Oncology #ImpactPitch #CME
Abhay Singh retweeted
More evidence that #ClonalHematopoiesis evolution is context dependent! 🧬 Clonal selection reflects both cancer therapy and germline genetics, with important implications for tMN development.
Huge congrats to @KellyLBolton @IrenaeusChan & colleagues!
nature.com/articles/s41588-0…
Abhay Singh retweeted
Beating the odds! Despite gastrectomy and chemo (for the second time in my life -lymphoma survivor now gastric cancer), I am glad to present my recently funded data @AIRC_it at this Fantastic Day1 of the #VEXAS international workshop in Milan🇮🇹 thanks to @Unicatt @unitorvergata2
Abhay Singh retweeted
Honored to present at two world-renowned institutions, the Institut Pasteur in Paris and the University of Oxford, on the role of bariatric surgery in treating obesity and obesity-related diseases. We shouldn’t stop treating #obesity.
Abhay Singh retweeted
Awarded an honorable distinction for our poster at @SocietyofHemOnc conference
Great collaboration through the Cure CML Consortium @ZhuoerXie @TalhaBadarMD
Abhay Singh retweeted
In our MDS “Challenging Case” discussion with @Dr_AmerZeidan we touched on:
✅ Rx options in 1L
✅ Rx at the time of progression
✅ AEs and management
Full 🗣️:
⭐️ oncbrothers.com/cc-mds-2026
⭐️ “Oncology Brothers” podcast
#OncTwitter #mmsm #HemeTwitter
Abhay Singh retweeted
Could CHIP be the missing link between chronic inflammation and residual🫀risk, and a key to precision anti-inflammatory therapy? Rheumatologic and other inflammatory diseases may provide some insights
ccjm.org/content/93/8/451.2
@CleClinicHVTI @CloneTracker @CarrawayHetty
Pleased to share our article on CHIP as a common, inflammation-mediated link to CVD, forming the clinical foundation for the CHIP Cardiology Clinic at Cleveland Clinic
ccjm.org/content/93/5/289
@ClevelandClinic @CleClinicHVTI @tavrkapadia @venumenon10 @LarsSvenssonMD
Abhay Singh retweeted
Wonderful presenting at @CCFcards noon conf on CHIP and🫀disease.
Lots to unpack from ethical (should we look for clones?) to scientific (how do 🧬 variants mediate 📈 CVD?) to clinical (how should we care for pts?) to future (high yield drug dev niches)
Thank you @venumenon10
Abhay Singh retweeted
Excellent presentation by Dr. Sudipto Mukherjee @MukherzSudipto at the 2026 National Rare Hematology Summit in Cleveland on precision thresholds to isolate malignancy-associated HLH (mHLH).
His discussion of the diagnostic limitations of HLH-2004 criteria, the validated HScore, and the Optimized HLH Inflammatory (OHI) Index thresholds
1. Ferritin >1,000 ng/mL
2. sCD25 >3,900 U/mL
offers practical guidance for timely intervention and improved outcomes.
@CloneTracker @CarrawayHetty @MukherzSudipto @binayshah
#OHHeme26 #RareHematology #HLH
Abhay Singh retweeted
Great inaugural Rare Hematologic disorders meeting hosted by @CarrawayHetty @binaytara @ClevelandClinic . Learnt a lot from my fantastic colleagues @AkritiGJain @pankitvachhani @ZhuoerXie @DrKateLurain @NamrataChandhok @CloneTracker . #mpnsm #chip
Abhay Singh retweeted
2024 brought 2 ASCO oral presentations
2025 brought manuscript rejections, grant rejections, and plenty of doubt
2026 brought another ASCO oral presentation and my first $1M+ award
Success is rarely linear. Keep showing up. Keep doing the work. Keep believing in yourself.
Abhay Singh retweeted
Today at @ClevelandClinic, we celebrated a major milestone: completion of enrollment for our randomized clinical trial comparing #BariatricSurgery, #Semaglutide, and #Tirzepatide.
Proud and grateful to work with an incredible team advancing the future of #obesity care & science. – at Cleveland, OH
Abhay Singh retweeted
Please join me in congratulating an outstanding group of young @CleClinicMD Hemonc fellows @CCF_IMCHIEFS graduating!! We are really excited about their next chapter including @ClevelandClinic @WinshipAtEmory @OhioState @MSKCancerCenter @HemOncFellows @CleClinicNews !
Abhay Singh retweeted
Excited to start the inaugural Marrow Master Class @karmanoscancer with fellow myeloid experts like @Dr_AmerZeidan @CloneTracker & many others ! Great meeting in beautiful Detroit Michigan organized by Dr. Suresh Balasubramaniam.
Abhay Singh retweeted
Pleased to share our article on CHIP as a common, inflammation-mediated link to CVD, forming the clinical foundation for the CHIP Cardiology Clinic at Cleveland Clinic
ccjm.org/content/93/5/289
@ClevelandClinic @CleClinicHVTI @tavrkapadia @venumenon10 @LarsSvenssonMD
Abhay Singh retweeted
Here is the link to our full discussion with @SKamath_MD on #BiliaryTractCancer Treatment Algorithm!
#Oncology #Cancer @ClevelandClinic @OncUpdates #OncTwitter #MedX
youtu.be/1t0iJx4utEM?si=seI4…
Abhay Singh retweeted
Congratulations to @RabiHannaMD my friend and colleague at @ClevelandClinic for leading the practice changing study on CRISPR gene editing for Sickle Cell Disease chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/nejm.org/doi/pdf/10.1056/NEJ… @NEJM @OncoAlert @IMG_Oncologists
Shay Taylor-Allen learned last week that she had matched with her first-choice residency pick, Yale School of Medicine — the very same hospital where she was born and later worked as a janitor. ABC News' Danny New has the story. abcnews.link/ZmFKePd





































